| |
FDA Cleared TAP®️ Micro Select enables remote blood collection with HALO™️ technology, a bladeless micro-needle array delivering virtually painless, large volume collection up to 500 uL. Click now.
|
|
Today's Big NewsMay 2, 2023 |
| By Angus Liu Workers at GSK’s Montrose facility in Scotland on Tuesday kicked off a series of strikes that will sequentially affect six of the company’s sites and last throughout May. |
|
|
|
By Max Bayer Pfizer is axing a handful of midstage medicines, most of which stemmed from the company's acquisition of Arena Pharmaceuticals. Company executives also noted on its first-quarter earnings call that it remains on the M&A hunt even after acquiring Seagen for almost $50 billion. |
By Andrea Park Less than two years after they first teamed up to distribute 3D-printed implants throughout the Asia-Pacific region—and only a few months after they expanded that partnership even further across the globe—Zimmer Biomet and Ossis are taking their relationship to the next level. |
By Zoey Becker In a new lawsuit between oncology giants, Bristol Myers Squibb claims AstraZeneca willfully infringed a key Opdivo patent. |
|
Thursday, May 25, 2023 | 10:00am ET / 7:00am PT Join the webinar and discover our MVA technology platform and explore the advantages for development and manufacturing of multiple vaccines and cell and gene therapeutics. Register now.
|
|
By Annalee Armstrong After releasing positive data for a bowel disease candidate in December, Prometheus headed into the J.P. Morgan healthcare conference in January as the talk of San Francisco. |
By Conor Hale Casana—a startup describing itself as “the industry leader in monitoring heart health through smart toilets”—has received a green light for its Heart Seat to log users’ pulse rate and blood oxygen saturation. |
By Angus Liu A New Jersey appellate court ruled that a group of insurers can’t use war as an argument to deny Merck coverage from the notorious NotPetya cyberattack in 2017. |
By Gabrielle Masson Incyte is whittling down its R&D pipeline, scrapping six discovery programs—one in a rare form of anemia and five in various cancers—to focus on eight remaining programs. |
By James Waldron Johnson & Johnson may have gone quiet on getting further CAR-Ts into the clinic beyond the success of its Legend-partnered Carvykti, but that’s about to change. |
By Andrea Park It’s a… sensor! Masimo welcomed the newest addition to its product family this week as it unveiled the Stork health-monitoring system for babies up to 18 months old. |
By Kevin Dunleavy Avadel Pharmaceuticals’ Lumryz has won approval from the FDA and becomes the first nightly, single-dose oral treatment for narcolepsy. The endorsement is a major threat to the market domination of Jazz Pharmaceuticals’ Xyrem, which requires two doses per night. |
By Helen Floersh The scientists who used CRISPR to eliminate HIV in mice have done it again, this time with a three-pronged approach that nearly doubled their success rate. |
Fierce podcastsDon't miss an episode |
| | This week on "The Top Line," we're launching a mini-series on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
|
|---|
|
|
|
Thursday, May 11, 2023 | 2pm ET / 11am PT Medical imaging holds a wealth of valuable data that can power R&D. Join us to learn how to overcome historical challenges such as the need for expertise in the field and a lack of comprehensive tools. We'll explore ways medical imaging data can be utilized in R&D, strategies for organizing and re-purposing legacy data, and more. Register now.
|
|
| eBookDiscover a game-changing approach to clinical research with Hybrid and Decentralized Clinical Trials (DCTs). Learn about the benefits, challenges, and key elements for success. Sponsored by: EvidentIQ |
| ResearchWhat role do the Library and Legal teams play in the drug development pipeline at Lilly? An import one – find out how. Sponsored by: CCC |
| WhitepaperThis paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| ResearchStrategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
| WhitepaperHow can eConsent provide a more flexible approach to informed consent? Sponsored by: YPrime |
| WhitepaperPreparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| |
|
